About Us
Prognostic tools for cancer treatment decision-making
PREDICT tools are developed by the University of Cambridge's Winton Centre for Risk and Evidence Communication. They estimate how different treatment decisions may affect survival outcomes, helping patients and clinicians make informed, personalised choices.
Since its launch in 2010 under the leadership of Professor Paul, PREDICT has evolved through successive versions—from V1 to V4. Over the years, the tools have incorporated additional clinical variables and more contemporary data, expanding from breast cancer to prostate, kidney, and ovarian cancer.
This work is supported by collaborative teams across the United Kingdom and the United States.
